Manufacturer record
Suraksha Pharma Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Suraksha Pharma Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between September 2024 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Suraksha Pharma Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol, Chlorpheniramine Maleate, Caffeine and Phenylephrine Hydrochloride Tablets | MAAI20724Mfg 2024-07 · Exp 2027-06 | Test for Disintegration onlyDisintegration | RDTL, Hubli, KarnatakaState lab | Feb 2026 |
| Metformin Hydrochloride Prolonged Release and Glimepiride Tablets I.P. | VPP11224Mfg 2024-12 · Exp 2026-11 | The sample received does not conform to I.P. 2022 specification with respect to the description only.Description | CDTL,HyderabadCDSCO lab | Nov 2025 |
| VALET-PM (Paracetamol and Diclofenac Potassium Tablets) | MAW40523Mfg 2023-05 · Exp 2026-04 | Test for Disintegration onlyDisintegration | DTL, Bengaluru, KarnatakaState lab | Oct 2025 |
| Floxages-OZ (Ofloxacin and Ornidazole Tablets IP) | SPY41223Mfg 2023-12 · Exp 2026-11 | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab | Sep 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.